Genentech, Inc. (NY:DNA)

View All ReportsStreetInsider.com Reports on DNA

Jul 8, 2009 09:12 AM Piper Jaffray Reiterates an 'Overweight' on Regeneron Pharmaceuticals (REGN); Raises Price Target

Jun 16, 2009 05:32 PM Biogen Idec (BIIB) Announces Decision By Arbitration Panel in Issues with Genentech (DNA)

Apr 8, 2009 05:08 PM Genentech (DNA) Announces Voluntary Withdrawal of Raptiva from the U.S. Market

Mar 31, 2009 03:40 PM FDA ODA Committee Recommends Accelerated Approval of Genentech's (DNA) Avastin for Brain Cancer

Mar 31, 2009 03:38 PM Genentech (DNA) said FDA committee unamiously recommends accelerated approval of Avastin in brain cancer

StreetInsider Reports on DNA by Category

• Analyst Ratings
• Mergers and Acquisitions
• Earnings
• Guidance
• Stock Buybacks
• Dividends
• Retail Sales
• Management Changes
• Insider Trades
• View More Categories

View All BlogsBlogs on DNA

Dec 20, 2009 07:10 AM Seattle Genetics Gets Boost from Cancer Drug Deal with Takeda

Dec 20, 2009 07:08 AM This Week's Failed Trials, Missed Targets in Biotech

Dec 6, 2009 10:13 AM How Do the Best Performing Stocks of Decade Compare to Predictions in 2000?

Dec 1, 2009 02:41 PM The Ugly Decade

Nov 5, 2009 05:34 AM Cramer's Mad Money - Distressed Tessera (11/4/09)

View All Comments Comments on recent DNA articles

Lester Wolff
on Mar 13, 2009
at 08:19 AM Genentech Oppenheimer has been wrong on DNA several times in the past.....I/m glad I did not follow their advice.
Article: Oppenheimer Downgrades Genentech (DNA) to Perform

Donna Dimke
on Mar 9, 2009
at 07:28 PM Roche/Genentech $95 gets DNA to the table, they should not settle for less than $100. plenty of reasons to be bullish on DNA.
Article: Genentech (DNA) Nearing Deal to Sell Itself to Roche for $95/Share -WSJ

John
on Mar 6, 2009
at 02:43 PM Roch buys Genentech Novartis should buy >10% of Genentech shares from the open market and hold to them. This way Roch will never be able to buy Genentech without going through Novartis. If Roche's acquisition of Genentech goes through, Novartis will never never even have a chance to acquire Roche.
Article: Genentech (DNA) Special Committee Urges Shareholders to Take No Action Related to Revised Offer from Roche

Thor
on Jan 2, 2009
at 03:04 PM Despite Lehman failure... Hats off to the Wall Street gurus who pulled off deals despite the carnage for example Teva's successful takeover of Barr was represented by Lehman until the venerable finance house went belly up. Nevertheless the deal close on time.
Article: Top 15 For 2008 (No. 14): M&A Wreckage

anon
on Aug 20, 2008
at 05:21 PM genentechDNA do you really think the board of directors will vote to let rosche take over their superlative personnel for the price citi is talking about? They will lose most of their personnel if they bully their ownership.
Article: Citi Downgrades Genentech (DNA) to Hold

Comments on DNA

No comments are currently available.

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?